These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 16498858

  • 21. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study.
    Rimmer J, Peake HL, Santos CM, Lean M, Bardin P, Robson R, Haumann B, Loehrer F, Handel ML.
    Clin Exp Allergy; 2007 Jan; 37(1):8-14. PubMed ID: 17210036
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Oral second generation antihistamines in allergic rhinitis].
    Riechelmann H.
    Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effects of Clara cell 10 (CC10) protein on symptoms and signs of allergic rhinitis.
    Widegren H, Andersson M, Greiff L.
    Ann Allergy Asthma Immunol; 2009 Jan; 102(1):51-6. PubMed ID: 19205286
    [Abstract] [Full Text] [Related]

  • 28. Histamine releasability after adenosine challenge in subjects with allergic and non-allergic rhinitis: possible implications for mast cell priming.
    Polosa R, Pagano C, Low JL, Church MK, Crimi N.
    Ann Ital Med Int; 1999 Jan; 14(2):86-93. PubMed ID: 10399370
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
    Kuna P, Bachert C, Nowacki Z, van Cauwenberge P, Agache I, Fouquert L, Roger A, Sologuren A, Valiente R, Bilastine International Working Group.
    Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Cetirizine from topical phosphatidylcholine-hydrogenated liposomes: evaluation of peripheral antihistaminic activity and systemic absorption in a rabbit model.
    Elzainy AA, Gu X, Simons FE, Simons KJ.
    AAPS J; 2004 Aug 10; 6(3):e18. PubMed ID: 15760103
    [Abstract] [Full Text] [Related]

  • 35. Glucocorticoids may not inhibit plasma exudation by direct vascular antipermeability effects in human airways.
    Greiff L, Andersson M, Svensson C, Alkner U, Persson CG.
    Eur Respir J; 1994 Jun 10; 7(6):1120-4. PubMed ID: 7925882
    [Abstract] [Full Text] [Related]

  • 36. Effects of cetirizine on substance P release in patients with perennial allergic rhinitis.
    Shirasaki H, Watanabe K, Kanaizumi E, Sato J, Konno N, Narita S, Himi T.
    Ann Otol Rhinol Laryngol; 2004 Dec 10; 113(12):941-5. PubMed ID: 15633894
    [Abstract] [Full Text] [Related]

  • 37. Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression.
    Ciprandi G, Pronzato C, Ricca V, Passalacqua G, Danzig M, Canonica GW.
    Clin Exp Allergy; 1997 Oct 10; 27(10):1175-83. PubMed ID: 9383258
    [Abstract] [Full Text] [Related]

  • 38. Effect of salbutamol on nasal symptoms and mast cell degranulation induced by adenosine 5' monophosphate nasal challenge.
    Russo C, Zeng D, Prosperini G, Spicuzza L, Guarino F, Polosa R.
    Clin Exp Allergy; 2005 Sep 10; 35(9):1192-6. PubMed ID: 16164447
    [Abstract] [Full Text] [Related]

  • 39. Low dose clemastine inhibits sneezing and rhinorrhea during the early nasal allergic reaction.
    Chung JH, deTineo ML, Naclerio RM, Sorrentino JV, Winslow CM, Baroody FM.
    Ann Allergy Asthma Immunol; 1997 Mar 10; 78(3):307-12. PubMed ID: 9087158
    [Abstract] [Full Text] [Related]

  • 40. Topical vasoconstrictor (oxymetazoline) does not affect histamine-induced mucosal exudation of plasma in human nasal airways.
    Svensson C, Pipkorn U, Alkner U, Baumgarten CR, Persson CG.
    Clin Exp Allergy; 1992 Mar 10; 22(3):411-6. PubMed ID: 1586878
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.